DrugPatentWatch Database Preview
Details for Patent: 8,778,997
» See Plans and Pricing
Which drugs does patent 8,778,997 protect, and when does it expire?
Patent 8,778,997 protects RAPIVAB and is included in one NDA.
This patent has thirty-three patent family members in fourteen countries.
Summary for Patent: 8,778,997
| Title: | Antiviral treatments |
| Abstract: | The invention provides unit dosage forms, kits, and methods useful for treating viral infections. |
| Inventor(s): | Babu; Yarlagadda Sudhakara (Birmingham, AL), Chand; Pooran (Birmingham, AL), Bantia; Shanta (Birmingham, AL), Arnold; Shane (Hoover, AL), Kilpatrick; John Michael (Helena, AL) |
| Assignee: | BioCryst Pharmaceuticals, Inc. (Birmingham, AL) |
| Application Number: | 13/103,562 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,778,997
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA IN ADULTS | Start Trial | ||||
| Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA IN PATIENTS 2 YEARS AND OLDER | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,778,997
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006341592 | Start Trial | |||
| Australia | 2007215156 | Start Trial | |||
| Australia | 2013216632 | Start Trial | |||
| Australia | 2016262644 | Start Trial | |||
| Brazil | PI0621552 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
